πŸ‡ΊπŸ‡Έ FDA
Patent

US 7811563

Anti-addl antibodies and uses thereof

granted A61PA61P25/00A61P25/28

Quick answer

US patent 7811563 (Anti-addl antibodies and uses thereof) held by Northwestern University expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P25/00, A61P25/28, A61P3/06, A61P43/00